Operatic Organ Trading Tale

Lionsgate and Twisted Pictures, the pair behind the “Saw” franchise, are teaming for under $25 million horror flick “Repo! The Genetic Opera” reports the trades.

Darren Lynn Bousman, director of both “Saw” sequels, will helm the rock opera project set in the not-so-distant future where an epidemic of organ failures devastates the planet, killing tens of millions.

As scientists gear for a massive organ harvest, a biotech giant comes up with easy organ payment plans. The catch? All financed organs are subject to legal default, including repossession at the hands of repo men.

Co-composers and screenwriters Terrence Zdunich and Darren Smith penned the story which was made into a 2002 theatrical run. Lionsgate will distribute the title in the US and the UK.